Allianz Asset Management
IMCR icon

Allianz Asset Management’s Immunocore IMCR Stock Holding History

Allianz Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,800
Closed -$1.03M – 2187
2024
Q1 		$1.03M Hold
15,800
– – ﹤0.01% 1401
2023
Q4 		$1.08M Buy
15,800
+4,200
+36% +$218K ﹤0.01% 1564
2023
Q3 		$602K Sell
11,600
-1,900
-14% -$112K ﹤0.01% 1864
2023
Q2 		$809 Buy
13,500
+7,600
+129% +$434K ﹤0.01% 2052
2023
Q1 		$292K Buy
+5,900
New +$332K ﹤0.01% 1996

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Allianz Asset Management's IMCR Position: Q2 2024 in Review

Allianz Asset Management sold out of Immunocore (IMCR) in Q2 2024, closing a stake of 15,800 shares — an estimated $1.03M sold.

Allianz Asset Management first reported a position in IMCR in Q1 2023 and held it in 5 quarters. The position peaked at $1.08M in Q4 2023. 138 funds tracked by Wall St. Rank hold IMCR as of Q2 2024.

  • Allianz Asset Management reported no remaining Immunocore position as of Q2 2024 after selling out during the quarter.
  • Allianz Asset Management sold 15,800 Immunocore shares in Q2 2024, an estimated $1.03M.
  • Allianz Asset Management first reported a position in Immunocore in Q1 2023 and held it in 5 quarters.
  • Allianz Asset Management's Immunocore position peaked at $1.08M in Q4 2023.
  • 138 funds tracked by Wall St. Rank held Immunocore as of Q2 2024.

Based on Allianz Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.